These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 17362283)
1. The clinical significance of "small" effects of smoking cessation treatments. West R Addiction; 2007 Apr; 102(4):506-9. PubMed ID: 17362283 [No Abstract] [Full Text] [Related]
2. The Cost-Effectiveness Analysis and Optimal Strategy of the Tobacco Control. Pang L; Liu S; Zhang X; Tian T Comput Math Methods Med; 2019; 2019():8189270. PubMed ID: 30863458 [TBL] [Abstract][Full Text] [Related]
3. An appraisal of smoking cessation aids. Mundey K Curr Opin Pulm Med; 2009 Mar; 15(2):105-12. PubMed ID: 19532024 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece. Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870 [TBL] [Abstract][Full Text] [Related]
9. Guidance for commissioners on the cost effectiveness of smoking cessation interventions. Parrott S; Godfrey C; Raw M; West R; McNeill A Thorax; 1998 Dec; 53 Suppl 5 Pt 2(Suppl 5):S1-38. PubMed ID: 10226676 [No Abstract] [Full Text] [Related]
10. [Methods and cost effectiveness of nicotine abstinence]. Górecka D Pol Merkur Lekarski; 2004 May; 16 Suppl 1():79-82. PubMed ID: 15524024 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of smoking cessation initiatives. Smoking cessation services show good return on investment. Foulds J BMJ; 2002 Mar; 324(7337):608-9. PubMed ID: 11885587 [No Abstract] [Full Text] [Related]
12. [Economic evaluation of smoking cessation interventions: have we overlooked something]. Trapero-Bertran M Arch Bronconeumol; 2009 May; 45(5):209-11. PubMed ID: 19395140 [No Abstract] [Full Text] [Related]
14. Implementation of a new 'opt-out' default for tobacco treatment is urgently needed, but requires free access to evidence-based treatments. Kotz D Addiction; 2015 Mar; 110(3):387-8. PubMed ID: 25678284 [No Abstract] [Full Text] [Related]
19. Development and validation of a microsimulation economic model to evaluate the disease burden associated with smoking and the cost-effectiveness of tobacco control interventions in Latin America. Pichon-Riviere A; Augustovski F; Bardach A; Colantonio L; Value Health; 2011; 14(5 Suppl 1):S51-9. PubMed ID: 21839900 [TBL] [Abstract][Full Text] [Related]
20. Cost effectiveness of full coverage of the medical management of smoking cessation in France. Chevreul K; Cadier B; Durand-Zaleski I; Chan E; Thomas D Tob Control; 2014 May; 23(3):223-30. PubMed ID: 23197369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]